Current interdisciplinary recommendations for the management of severe postpartum hemorrhage (PPH);Aktuelle interdisziplinäre Handlungsempfehlungen bei schweren peri-(post-)partalen Blutungen (PPH)

Geburtshilfe und Frauenheilkunde

Volumn 71, Issue 7, 2011, Pages 577-588

  Lier, H ^a   Rath, W ^b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

blood coagulation factors; drug therapy; erythrocyte transfusion; fibrinogen; fibrinolysis; postpartum hemorrhage; therapeutic use

Indexed keywords

CALCIUM; DESMOPRESSIN; FIBRINOGEN; FRESH FROZEN PLASMA; HEMOGLOBIN; HEPARIN; PROTHROMBIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN; TRANEXAMIC ACID;

ACIDOSIS; ANTICOAGULANT THERAPY; ARTICLE; BLOOD OXYGENATION; BLOOD TRANSFUSION; BLOOD VOLUME; BODY TEMPERATURE; CALCIUM BLOOD LEVEL; COLLOID; CRYSTALLOID; DISEASE SEVERITY; FIBRINOLYSIS; HEALTH STATUS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOVOLEMIC SHOCK; HYSTERECTOMY; INTERDISCIPLINARY EDUCATION; MATERNAL CARE; MATERNAL MORTALITY; MEDICAL EDUCATION; PATIENT ASSESSMENT; PATIENT MONITORING; POINT OF CARE TESTING; POSTPARTUM HEMORRHAGE; PRACTICE GUIDELINE; PREVENTION STUDY; SALVAGE THERAPY; THROMBOCYTOPATHY; THROMBOELASTOGRAPHY; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 79960938079     PISSN: 00165751     EISSN: 14388804     Source Type: Journal    
DOI: 10.1055/s-0030-1271194     Document Type: Article

References (92)

1. Mousa H A., Walkinshaw S. Major postpartum haemorrhage. Curr Opin Obstet Gynecol 2001 13 595-603 (Pubitemid 33108903)
2. Khan K S., Wojdyla D, Say L et al. WHO analysis of causes of maternal death: a systematic review. Lancet 2006 367 1066-1074
3. Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: case-control study. BMJ 2001 322 1089-1093 (Pubitemid 32411179)
4. Knight M, Callaghan W M., Berg C et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth 2009 9 55
5. Royal College of Obstetricians and Gynecologists (ROCG). Postpartum haemorrhage, prevention and management (Green-top 52). Im Internet: http://www.rcog.org.uk/womens-health/clinical-guidance/prevention-and- management-postpartum-haemorrhage-green-top-52 Stand: 20.6.2009
6. Callaghan W M., Kuklina E V., Berg C J. Trends in postpartum hemorrhage: United States, 1994-2006. Am J Obstet Gynecol 2010 202 353-356
7. Rossen J, Okland I, Nilsen O B. et al. Is there an increase of postpartum hemorrhage, and is severe hemorrhage associated with more frequent use of obstetric interventions? Acta Obstet Gynecol Scand 2010 89 1248-1255
8. Samangaya R, Pennington R, Vause S. Factors relating to a rising incidence of major postpartum haemorrhage. BJOG 2010 117 370-371
9. Dupont C, Touzet S, Colin C et al. Incidence and management of postpartum haemorrhage following the dissemination of guidelines in a network of 16 maternity units in France. Int J Obstet Anesth 2009 18 320-327
10. Oyelese Y, Ananth C V. Postpartum hemorrhage: epidemiology, risk factors, and causes. Clin Obstet Gynecol 2010 53 147-156
11. Berg C J., Harper M A., Atkinson S M. et al. Preventability of pregnancy-related deaths: results of a state-wide review. Obstet Gynecol 2005 106 1228-1234 (Pubitemid 41668939)
12. cemach. Why mothers die 2003-2005. The seventh report of the confidential enquiries into maternal deaths in the United Kingdom. Im Internet: http://www.cemach.org.uk Stand: 6.1.2008
13. Upadhyay K, Scholefield H. Risk management and medicolegal issues related to postpartum haemorrhage. Best Pract Res Clin Obstet Gynaecol 2008 22 1149-1169
14. Bundesärztekammer (BK). Querschnitts-Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. (4.Auflage 2008, zuletzt geändert Januar 2011). Im Internet: http://www.bundesaerztekammer.de/page.asp?his=0.6. 3288.8906 Stand: 8.1.2011
15. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). AWMF-Leitlinie 015/063: Diagnose und Therapie der peripartalen Blutung. Im Internet: http://leitlinien.net/ Stand: 15.1.2011
16. Leduc D, Senikas V, Lalonde A B. et al. Active management of the third stage of labour: Prevention and treatment of postpartum hemorrhage: No.235 October 2009 (replaces No.88, April 2000). Int J Gynaecol Obstet 2010 108 258-267
17. Rath W, Schneider M. Definitionen und Diagnostik postpartaler Blutungen (PPH): Unterschätzte Probleme! Geburtsh Frauenheilk 2010 70 36-40
18. Ickx B E. Fluid and blood transfusion management in obstetrics. Eur J Anaesthesiol 2010 27 1031-1035
19. Thachil J, Toh C H. Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Rev 2009 23 167-176
20. Pfanner G. Geburtshilfliche Blutungskomplikationen. Hämostaseologie 2006 26 S56-S63
21. Franchini M. Haemostasis and pregnancy. Thromb Haemost 2006 95 401-413
22. Ahonen J, Stefanovic V, Lassila R. Management of post-partum haemorrhage. Acta Anaesthesiol Scand 2010 54 1164-1178
23. Fuller A J., Bucklin B A. Blood product replacement for postpartum hemorrhage. Clin Obstet Gynecol 2010 53 196-208
24. McLintock C. Obstetric haemorrhage. Thromb Res 2009 123 S30-S34
25. Cabero Roura L, Keith L G. Post-partum haemorrhage: diagnosis, prevention and management. J Matern Fetal Neonatal Med 2009 22 38-45
26. Winter C, Macfarlane A, Deneux-Tharaux C et al. Variations in policies for management of the third stage of labour and the immediate management of postpartum haemorrhage in Europe. BJOG 2007 114 845-854 (Pubitemid 46918709)
27. Skupski D W., Lowenwirt I P., Weinbaum F I. et al. Improving hospital systems for the care of women with major obstetric hemorrhage. Obstet Gynecol 2006 107 977-983
28. cemach. Confidential enquiry into maternal and child health. Perinatal Mortality 2005: England, Wales and Northern Ireland. London CEMACH 2007
29. Zelop C M. Postpartum hemorrhage: becoming more evidence-based. Obstet Gynecol 2011 117 3-5
30. Driessen M, Bouvier-Colle M H., Dupont C et al. Postpartum hemorrhage resulting from uterine atony after vaginal delivery: factors associated with severity. Obstet Gynecol 2011 117 21-31
31. Bonnar J. Massive obstetric haemorrhage. Baillieres Best Pract Res Clin Obstet Gynaecol 2000 14 1-18 (Pubitemid 30153867)
32. Hofmeyr G J., Mohlala B K. Hypovolaemic shock. Best Pract Res Clin Obstet Gynaecol 2001 15 645-662 (Pubitemid 32754898)
33. Coker A, Oliver R. Definitions and Classifications. In: Lynch C B. Keith L Lalonde A Karoshi M eds. A Textbook of postpartum Hemorrhage. Dumfriesshire Sapiens Publishing 2006 11-16
34. Mukherjee S, Arulkumaran S. Post-partum haemorrhage. Obstet Gynaecol Reprod Med 2009 19 121-126
35. Karpati P C., Rossignol M, Pirot M et al. High incidence of myocardial ischemia during postpartum hemorrhage. Anesthesiology 2004 100 30-36 (Pubitemid 38031651)
36. Gallos G, Redai I, Smiley R M. The role of the anesthesiologist in management of obstetric hemorrhage. Semin Perinatol 2009 33 116-123
37. Hofer S, Schreckenberger R, Heindl B et al. Blutungen während der Schwangerschaft. Anaesthesist 2007 56 1075-1089
38. Wise A, Clark V. Strategies to manage major obstetric haemorrhage. Curr Opin Anaesthesiol 2008 21 281-287 (Pubitemid 351658922)
39. Rajan P V., Wing D A. Postpartum hemorrhage: evidence-based medical interventions for prevention and treatment. Clin Obstet Gynecol 2010 53 165-181
40. Kuczkowski K M. Anesthesia for the repeat cesarean section in the parturient with abnormal placentation: What does an obstetrician need to know? Arch Gynecol Obstet 2006 273 319-321
41. Siddiqui N, Goldszmidt E, Haque S U. et al. Ultrasound simulation of internal jugular vein cannulation in pregnant and non-pregnant women. Can J Anaesth 2010 57 966-972
42. Jin S L., Yu B W. Effects of acute hypervolemic fluid infusion of hydroxyethyl starch and gelatin on hemostasis and possible mechanisms. Clin Appl Thromb Hemost 2010 16 91-98
43. Lier H, Krep H, Schroeder S et al. Preconditions of hemostasis in trauma: a review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. J Trauma 2008 65 951-960
44. Kashuk J L., Moore E E., Sawyer M et al. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg 2010 252 434-442
45. Stainsby D, MacLennan S, Thomas D et al. Guidelines on the management of massive blood loss. Br J Haematol 2006 135 634-641 (Pubitemid 44674073)
46. Lier H, Krep H, Schochl H. Gerinnungsmanagement bei der Polytraumaversorgung. Anaesthesist 2009 58 1010-1026
47. Allam J, Cox M, Yentis S M. Cell salvage in obstetrics. Int J Obstet Anesth 2008 17 37-45 (Pubitemid 350298890)
48. King M, Wrench I, Galimberti A et al. Introduction of cell salvage to a large obstetric unit: the first six months. Int J Obstet Anesth 2009 18 111-117
49. Fong J, Gurewitsch E D., Kang H J. et al. An analysis of transfusion practice and the role of intraoperative red blood cell salvage during cesarean delivery. Anesth Analg 2007 104 666-672
50. Geoghegan J, Daniels J P., Moore P A. et al. Cell salvage at caesarean section: the need for an evidence-based approach. BJOG 2009 116 743-747
51. Ashworth A, Klein A A. Cell salvage as part of a blood conservation strategy in anaesthesia. Br J Anaesth 2010 105 401-416
52. National Institute for Health and Clinical Excellence (NICE). Intraoperative blood cell salvage in obstetrics. Im Internet: http://guidance.nice.org.uk/IPG144/Guidance/pdf/English Stand: 6.1.2011
53. The Association of Anaesthetists of Great Britain and Ireland (AAGBI). Safety guideline blood transfusion and the anaesthetist: intra-operative cell salvage. Im Internet: http://aagbi.org/publications/guidelines/docs/cell%2520- salvage-2009-amended.pdf Stand: 6.1.2011
54. Rossi A C., Lee R H., Chmait R H. Emergency postpartum hysterectomy for uncontrolled postpartum bleeding: a systematic review. Obstet Gynecol 2010 115 637-644
55. Franchini M, Lippi G, Franchi M. The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage. BJOG 2007 114 8-15 (Pubitemid 44923926)
56. Holcomb J B., Hess J R. Early massive trauma transfusion: state of the art. J Trauma 2006 60 S1-S2 (Pubitemid 43898554)
57. Stainsby D, Jones H, Asher D et al. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 2006 20 273-282 (Pubitemid 44428107)
58. Tinegate H N., Thompson C L., Jones H et al. Where and when is blood transfused? An observational study of the timing and location of red cell transfusions in the north of England. Vox Sang 2007 93 229-232 (Pubitemid 47373986)
59. Arbeitskreis Blut des Robert Koch-Instituts (RKI). Votum 39 Maβnahmen zur Vermeidung der transfusionsbedingten Lungeninsuffizienz (TRALI). Bundesgesundheitsbl 2009 52 572
60. Arbeitskreis Blut des Robert Koch-Instituts (RKI). Ergänzung zum Votum 38. Im Internet: http://www.rki.de/cln-169/nn-206138/DE/Content/Infekt/ Blut/AK-Blut/Voten/Uebersicht/V-38/V38-manuskript,templateId=raw,property= publicationFile.pdf/V38-manuskript.pdf Stand: 6.1.2011
61. Sarani B, Dunkman W J., Dean L et al. Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection. Crit Care Med 2008 36 1114-1118 (Pubitemid 351482658)
62. Watson G A., Sperry J L., Rosengart M R. et al. Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. J Trauma 2009 67 221-227
63. Hanke A A., Dellweg C, Kienbaum P et al. Effects of desmopressin on platelet function under conditions of hypothermia and acidosis: an in vitro study using multiple electrode aggregometry. Anaesthesia 2010 65 688-691
64. Rossaint R, Bouillon B, Cerny V et al. Management of bleeding following major trauma: an updated European guideline. Crit Care 2010 14 R52
65. Hardy J F., De M P., Samama M. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth 2004 51 293-310 (Pubitemid 38701939)
66. Moloney W C., Phillips L L., Pritchard J A. et al. Management of the obstetrical patient with hemorrhage due to an acute or subacute defibrination syndrome. Blood 1959 14 1354-1367
67. Huissoud C, Carrabin N, Audibert F et al. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG 2009 116 1097-1102
68. Brohi K, Cohen M J., Ganter M T. et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 2008 64 1211-1217 (Pubitemid 351671214)
69. Lier H, Bottiger B W., Hinkelbein J et al. Coagulation management in multiple trauma: a systematic review. Intensive Care Med 2011 37 572-582
70. Mercier F J., Bonnet M P. Use of clotting factors and other prohemostatic drugs for obstetric hemorrhage. Curr Opin Anaesthesiol 2010 23 310-316
71. Fries D, Innerhofer P, Perger P et al. Gerinnungsmanagement bei traumatisch bedingter Massivblutung. Empfehlungen der Arbeitsgruppe für perioperative Gerinnung der GARI. Anasthesiol Intensivmed Notfallmed Schmerzther 2010 45 552-561
72. Shakur H, Roberts I, Bautista R et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010 376 23-32
73. World Health Organisation (WHO). WHO guidelines for the management of postpartum haemorrhage and retained placenta. Im Internet: http://www.who.int/ reproductivehealth/publications/maternal-perinatal-health/9789241598514/en/ Stand: 6.1.2011
74. Ferrer P, Roberts I, Sydenham E et al. Anti-fibrinolytic agents in post partum haemorrhage: a systematic review. BMC Pregnancy Childbirth 2009 9 29
75. Novikova N, Hofmeyr G J. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2010 7 CD007872
76. Sekhavat L, Tabatabaii A, Dalili M et al. Efficacy of tranexamic acid in reducing blood loss after cesarean section. J Matern Fetal Neonatal Med 2009 22 72-75
77. Ducloy-Bouthors A S., Jude B, Duhamel A et al. High-dose tranexamic acid reduces blood loss in post-partum haemorrhage. Crit Care 2011 15 R117
78. Shakur H, Elbourne D, Gulmezoglu M et al. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials 2010 11 40
79. Chowdhury P, Saayman A G., Paulus U et al. Efficacy of standard dose and 30ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004 125 69-73 (Pubitemid 38453280)
80. Szecsi P B., Jorgensen M, Klajnbard A et al. Haemostatic reference intervals in pregnancy. Thromb Haemost 2010 103 718-727
81. Charbit B, Mandelbrot L, Samain E et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007 5 266-273 (Pubitemid 46139450)
82. Mackie I J., Kitchen S, Machin S J. et al. Guidelines on fibrinogen assays. Br J Haematol 2003 121 396-404 (Pubitemid 36628330)
83. Franchini M, Franchi M, Bergamini V et al. The use of recombinant activated FVII in postpartum hemorrhage. Clin Obstet Gynecol 2010 53 219-227
84. Welsh A, McLintock C, Gatt S et al. Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage. Aust N Z J Obstet Gynaecol 2008 48 12-16 (Pubitemid 351239149)
85. Fries D, Haas T, Salchner V et al. Gerinnungsmanagement beim Polytrauma. Anaesthesist 2005 54 137-144 (Pubitemid 40379360)
86. Tanaka K A., Taketomi T, Szlam F et al. Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P). Anesth Analg 2008 106 732-738 (Pubitemid 351301386)
87. Levi M, Levy J H., Andersen H F. et al. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010 363 1791-1800
88. NovoNordisk. Fachinformation NovoSeven, Oktober 2010. Kapitel Thrombembolische Ereignisse Im Internet: http://www.fachinfo.de/data/fi/jsearch? praep Stand: 12.2.2011
89. Afshari A, Wetterslev J, Brok J et al. Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis. BMJ 2007 335 1248-1251
90. Detti L, Mecacci F, Piccioli A et al. Postpartum heparin therapy for patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) is associated with significant hemorrhagic complications. J Perinatol 2005 25 236-240 (Pubitemid 40515073)
91. McDonald V, Ryland K. Coagulopathy in trauma: optimising haematological status. Trauma 2008 10 109-123 (Pubitemid 351818752)
92. Djelmis J, Ivanisevic M, Kurjak A et al. Hemostatic problems before, during and after delivery. J Perinat Med 2001 29 241-246 (Pubitemid 32574264)